Resources>Citations Database>NF1 deficiency drives metabolic reprogramming in ER+ breast cancer

NF1 deficiency drives metabolic reprogramming in ER+ breast cancer

Biointron 2024-01-10

Authors: Rachel Rae J House, Elizabeth A Tovar, Luke N Redlon, Curt J Essenburg, Patrick S Dischinger, Abigail E Ellis, Ian Beddows, Ryan D Sheldon, Evan C Lien, Carrie R Graveel, Matthew R Steensma

Journal: Molecular Metabolism

PubMed ID: 38216123

DOI: https://doi.org/10.1016/j.molmet.2024.101876

Products & Services: iNF-07E (gifted by iNFiXion Bioscience, Biointron, Cat# B21900201, primary 1:500, secondary 1:2000

Subscribe to our Citations Database
Recommended Articles
MRNA Profiling Involved in Triggering of STAT1 with Regulatory Involvement of IRF7, PTPRF, and miR-145p in Patients Suffering from Gall Bladder Carcinoma
Nov 25, 2025
Droplet Squeeze Microfluidic Platform for Generating Extracellular Vesicle Hybrids for Drug Delivery

Droplet Squeeze Microfluidic Platform for Generating Extracellular Vesicle Hybri……

Aug 07, 2025
Self-Assembling Multi-Antigen T Cell Hybridizers for Precision Immunotherapy of Multiple Myeloma

Self-Assembling Multi-Antigen T Cell Hybridizers for Precision Immunotherapy of ……

Aug 01, 2025
Inhibition of long-lived plasma cells, a critical role for Telitacicept treatment to systemic lupus erythematosus

Inhibition of long-lived plasma cells, a critical role for Telitacicept treatmen……

Jul 30, 2025

Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.